We are Sorry, This Page doesn't Exist

BioCryst Pharmaceuticals shares were absolutely crushed in Tuesday’s session after the company announced late-stage results for its study in hereditary angioedema patients......»»

Intercept Pharmaceuticals shares jumped on Tuesday after the firm announced results for its Phase 3 Regenerate study of obeticholic acid in patients with liver fibrosis due to nonalcoholic........»»

A Triangle drugmaker that's seen positive results with its Covid-19 treatment internationally can now start treating patients in the U.S. Raleigh's RedHill Biopharma (Nasdaq: RDHL) has received approval from the U.S. Food and Drug Administration .....»»

A key U.S. government trial of Gilead Sciences Inc's experimental coronavirus treatment may yield results as early as mid-May, according to the study's lead investigator, after doctors clamored to enroll their patients in the study......»»

Apellis Pharmaceuticals shares jumped on Tuesday after the firm announced positive results from its late stage study in adults with paroxysmal nocturnal hemoglobinuria (PNH). Specifically, the data........»»

Xeris Pharmaceuticals Inc. shares rallied in the extended session Monday after the drug maker said its diabetes treatment showed positive results in a .....»»

Shares of Hepion Pharm.....»»

Reata Pharmaceuticals Inc. shares were halted in the extended session Monday as the biotech drug developer reported positive results from a late-stage kidney disease treatment study. Reata shares were flat, following a .....»»

Amgen Inc. said Wednesday data from phase 1 studies of an investigational bispecific T cell engager (BiTE) molecules, updated with investigational AMG 420 results for the treatment .....»»

AZEDRA® (iobenguane I 131) U.S. Commercial Launch Advancing with 22 Treatment Requests from Patients Received and 12 Centers Throughout the U.S. are Ready to Treat Patients Phase 2 Trial of 1095 Initiated with Enrollment to Begin 2Q.....»»

- Announced updated clinical data from Phase 2 basket study of setmelanotide in MC4R pathway heterozygous (HET) obesity, demonstrating consistent weight and hunger responses in patients with high-i.....»»

Merck & Co. Inc. said Friday that a Phase 3 trial evaluating Keytruda as a first-line treatment for gastric cancer failed to show improvement in patients' overall or progression-free survival when compared with chemotherapy. Shares of th.....»»

Supernus (SUPN) releases top-line results from the fourth phase III study on SPN-812 for the treatment of attention deficit hyperactivity disorder. Wan.....»»

Madrigal Pharmaceuticals presented "statistically significant" results from midstage testing of its lead new drug candidate for NASH during Monday's annual meeting of the American Association for the Study of Liver Diseases in San Francisco. The Conshoh.....»»

Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients with idiopathic and diabetic gastroparesis......»»

Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity........»»

Ra Pharmaceuticals shares jumped on Monday after the company announced positive mid-stage results for the treatment of generalized myasthenia gravis......»»

Aptinyx shares were absolutely crushed on Wednesday after the firm reported midstage results from its clinical study in patients with painful diabetic peripheral neuropathy......»»

Shares of Ultragenyx Pharmaceutical Inc. rose 2.9% in premarket trade Tuesday after the company announced positive results from a safety and efficacy study looking at a treatment for patients with lo.....»»

Spirulina Significantly Reduces COVID-19 Mortality: Study Authored by Marina Zhang via The Epoch Times (emphasis ours), Hospitalized COVID-19 patients who took spirulina had a lower risk of death than those who did not, according to results .....»»